+106.6%
ARES vs THC
+250.3%
-143.7%
-50.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | +0.6% | -1.6% | -1.1% |
| 7D | -1.7% | -0.7% | -1.0% | -1.5% |
| 30D | +0.3% | +1.3% | -1.0% | -0.2% |
| 3M | +8.5% | +64.2% | -55.8% | -6.4% |
| 6M | +23.5% | +8.3% | +15.2% | +19.5% |
| YTD | -11.2% | +33.4% | -44.6% | -19.8% |
| 1Y | -19.3% | +37.7% | -57.0% | -28.3% |
| 3Y | +48.7% | +236.8% | -188.1% | -6.0% |
| All | +106.6% | +250.3% | -143.7% | +28.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling